查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1830961

质子治疗系统市场

Proton Therapy Systems Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格
简介目录

质子治疗系统市场预计将从 2024 年的 15.6107 亿美元扩大到 2031 年的 32.7484 亿美元，2025-2031 年期间的复合年增长率预计为 11.2%。

市场洞察与分析师观点：质子治疗系统市场的预测可以帮助该领域的利害关係人制定成长策略。

质子治疗系统是一种先进的医疗设备，用于对肿瘤进行高精度放射治疗。这些系统体积庞大，由加速器（迴旋加速器）、束流传输系统、能量选择系统及旋转机架辐照设备所组成。由于质子治疗在治疗特定癌症类型方面疗效显着，全球对质子治疗的需求日益增长。随着癌症发生率的上升，对先进治疗的需求不断增长，以及政府对质子治疗设施的支持力度不断加大，这些因素正在推动质子治疗系统市场的成长。然而，质子治疗系统的高成本和占地面积对市场扩张构成了挑战。此外，个人化治疗方法的日益普及以及技术的进步预计将在未来几年为质子治疗系统市场带来新的趋势。

成长动力：癌症发生率上升，对先进治疗的需求增加，推动市场成长根据国际癌症研究机构 (IARC) 的数据，2022 年肺癌、乳癌和摄护腺癌的发生率最高，年龄标准化率分别为每 10 万人口 23.6 例、47.1 例和 29.4 例。 IARC 估计表明，预计癌症病例总数将从 2022 年的 1,998 万增加到 2030 年的 2,371 万，到 2045 年将达到 3,097 万。各种癌症类型，包括头颈癌（鼻癌、口腔癌、眼癌和喉癌）和脑癌，都有特定的治疗需求，导致对调强质子治疗 (IMPT) 等先进治疗方式的需求增加。传统放射疗法，例如X射线放射疗法，也会使肿瘤周围的健康组织暴露于辐射之下，从而产生副作用并可能导致继发性癌症。相较之下，质子治疗能够有效治疗脑部和头颈部的复杂肿瘤，同时最大限度地减少对邻近健康组织的伤害。因此，癌症的高发病率和对先进治疗方案的需求正在推动质子治疗系统市场的成长。

策略性洞察限制：质子治疗系统成本高、占地面积大质子治疗系统是一种用于精准放射治疗肿瘤的复杂医疗设备。系统体积庞大，包括加速器（迴旋加速器）、束流传输系统、能量选择系统和旋转机架辐照设备，占用空间大，设备成本高。据宾州大学 (Oncolink) 称，质子治疗系统中的迴旋加速器重达 200 吨，直径为 6-12 英尺。机架重约 100 吨，直径 40 英尺。 2021 年发表在 IOPscience 上的一项研究表明，即使是紧凑型设计（单室设置）也需要 100 平方米的面积，而多室质子治疗系统则需要 200-400 平方米的空间。

此外，质子治疗系统高度资本密集。例如，单室系统的成本约为3000万至5000万美元，而多机架质子治疗系统的起价约为3亿美元，通常仅安装在大型医院和大学系统中。因此，高额的资本投入和所需的庞大安装空间是阻碍质子治疗系统市场成长的重要因素。

报告细分和范围：透过检查以下细分来分析质子治疗系统市场：设定类型和应用。

根据设置类型，市场分为单室和多室。 2022年，多室部分在质子治疗系统市场中占据了更大的份额。此外，预计单室部分在预测期内将呈现更快的复合年增长率。

根据应用，市场分为脑部和中枢神经系统癌症、头颈癌、摄护腺癌、乳癌、肺癌、胃肠道癌症等。脑部和中枢神经系统癌症领域在2022年占据了质子治疗系统市场的最大份额，预计在预测期内将实现最高的复合年增长率。

区域分析：从地理上讲，质子治疗系统市场报告的范围涵盖北美、欧洲、亚太地区、南美和中美以及中东和非洲。 2022 年，北美占据了最大的市场份额。先进医疗设备的日益普及和采用、癌症的高发病率以及主要参与者的产品创新促进了北美质子治疗系统市场的成长。根据美国癌症协会的估计，美国在 2023 年记录了约 195 万例新发癌症病例和约 61 万例癌症相关死亡病例，与 2020 年报告的 160 万例病例和 60 万例死亡病例相比显着增加。根据粒子治疗合作组织的数据，到 2023 年底，美国的质子治疗系统数量位居全球第一，共有 46 套治疗设施。

质子治疗系统市场报告范围产业发展与未来机会：正如公司新闻稿所报导的，质子治疗系统市场主要参与者的几项策略发展重点如下：

2024年1月，OncoRay推出了全身磁振造影引导质子治疗系统原型，该系统旨在治疗期间利用磁振造影 (MRI) 即时追踪移动的肿瘤。 MRI 增强了肿瘤的可视性，与传统影像方法相比，其对比度更高，能够更准确地将肿瘤与周围健康组织区分开来，并更好地定义照射区域。 2023年12月，养和医疗集团在香港筲箕湾阿公岩的养和东区医疗中心开设了一家新的质子治疗中心。该中心拥有先进的质子治疗系统和两间最先进的治疗室，包括两台半旋转质子治疗机架、最新的光束传输系统和同步加速器。竞争格局和主要公司：质子治疗系统市场报告中介绍的知名公司包括 Varian Medical Systems Inc、住友重工有限公司、日立有限公司、Ion Beam Applications SA、Mevion Medical Systems、Provision Healthcare LLC、ProTom International、Optivus Proton Therapy Inc、Advanced Oncotherapy plc 和 B dot Medical Inc。这些公司专注于开发新技术、增强现有产品并扩大其地理覆盖范围以满足日益增长的全球需求。

目录

第一章：简介

第 2 章：执行摘要

  • 关键见解
  • 市场吸引力分析

第三章：研究方法

第四章：质子治疗系统市场格局

  • 概述
  • PEST分析
  • 生态系分析
    • 价值链中的供应商列表

第五章：质子治疗系统市场－关键市场动态

  • 关键市场驱动因素
  • 主要市场限制因素
  • 关键市场机会
  • 未来趋势
  • 驱动因素和限制因素的影响分析

第六章：质子治疗系统市场-全球市场分析

  • 质子治疗系统 - 全球市场概览
  • 质子治疗系统－全球市场及2030年预测

第七章：质子治疗系统市场-收入分析-依设定类型，2020-2030

  • 概述
  • 单人房
  • 多房间

第 8 章：质子治疗系统市场 - 收入分析 - 按应用，2020-2030 年

  • 概述
  • 脑部和中枢神经系统癌症
  • 头颈癌
  • 摄护腺癌
  • 乳癌
  • 肺癌
  • 胃肠道癌症
  • 其他的

第九章：质子治疗系统市场-收入分析，2020-2030-地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 欧洲其他地区
  • 亚太
    • 澳洲
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第十章：产业格局

  • 併购
  • 协议、合作、合资企业
  • 新产品发布
  • 扩张和其他策略发展

第 11 章：竞争格局

  • 关键参与者的热图分析
  • 公司定位与集中度

第 12 章：质子治疗系统市场 - 主要公司简介

  • Varian Medical Systems Inc
  • Hitachi Ltd
  • Sumitomo Heavy Industries Ltd
  • Ion Beam Applications SA
  • Mevion Medical Systems
  • Provision Healthcare LLC
  • ProTom International
  • Optivus Proton Therapy Inc
  • Advanced Oncotherapy plc
  • B dot Medical Inc

第 13 章：附录

简介目录
Product Code: TIPHE100001160

The proton therapy systems market is anticipated to expand from US$ 1,561.07 million in 2024 to US$ 3,274.84 million by 2031, with an estimated CAGR of 11.2% during the period of 2025-2031.

Market Insights and Analyst Perspective:The forecast for the proton therapy systems market can assist stakeholders in this sector in formulating their growth strategies.

A proton therapy system is a sophisticated medical apparatus utilized for delivering highly accurate radiation treatment for tumors. These systems are substantial in size and comprise an accelerator (cyclotron), beam transport system, energy selection system, and rotating gantry irradiation equipment. Due to their efficacy in treating specific cancer types, there is an increasing global demand for proton therapy. Factors such as the rising need for advanced treatments alongside the increasing incidence of cancer, as well as growing governmental support for proton therapy facilities, are driving the growth of the proton therapy systems market. However, the high costs and large footprint of proton therapy systems pose challenges to market expansion. Additionally, the increasing adoption of personalized treatment methods coupled with technological advancements is expected to introduce new trends in the proton therapy systems market in the years ahead.

Growth Drivers:Increasing Demand for Advanced Treatments Amid Rising Cancer Incidence Fuels Market Growth

According to the International Agency for Research on Cancer (IARC), lung, breast, and prostate cancers had the highest incidence rates in 2022, with age-standardized rates of 23.6, 47.1, and 29.4 cases per 100,000 population, respectively. IARC estimates indicate that the total number of cancer cases is projected to rise from 19.98 million in 2022 to 23.71 million by 2030 and 30.97 million by 2045. Various cancer types, including head and neck cancers (nasal, oral, eye, and larynx) and brain cancers, have specific treatment needs, leading to a heightened demand for advanced treatment modalities such as intensity-modulated proton therapy (IMPT). Traditional radiation therapies, like X-ray radiation therapy, also expose healthy tissues surrounding the tumor to radiation, resulting in side effects and potential secondary cancers. In contrast, proton therapy effectively treats complex tumors in the brain and head and neck regions while minimizing damage to adjacent healthy tissues. Therefore, the high prevalence of cancer and the demand for advanced treatment options are propelling the growth of the proton therapy systems market.

Strategic Insights

Restraint:High Costs and Large Footprint of Proton Therapy Systems

A proton therapy system is a sophisticated medical device utilized for precise radiation treatment of tumors. It is a large apparatus that includes an accelerator (cyclotron), beam transport system, energy selection system, and rotating gantry irradiation equipment, resulting in significant space requirements and high equipment costs. According to the University of Pennsylvania (Oncolink), cyclotrons in proton therapy systems can weigh up to 200 tons and have diameters of 6-12 feet. The gantry can weigh around 100 tons and measure 40 feet in diameter. A study published in 2021 in IOPscience indicates that even a compact design (single-room setup) requires an area of 100 sq. m., while multi-room proton therapy systems need 200-400 sq. m. of space.

Moreover, proton therapy systems are highly capital-intensive. For example, a single-room system may cost approximately US$ 30-50 million, while multi-gantry proton systems can start at around US$ 300 million, typically installed only in large hospitals and university systems. Consequently, the substantial capital investment and extensive installation space required are significant factors hindering the growth of the proton therapy systems market.

Report Segmentation and Scope:The analysis of the proton therapy systems market has been conducted by examining the following segments: setup type and application.

By setup type, the market is divided into single room and multi room. The multi room segment held a larger share of the proton therapy systems market in 2022. Furthermore, the single room segment is expected to exhibit a faster CAGR during the forecast period.

In terms of application, the market is categorized into brain and central nervous system cancer, head and neck cancer, prostate cancer, breast cancer, lung cancer, gastrointestinal cancer, and others. The brain and central nervous system cancer segment accounted for the largest share of the proton therapy systems market in 2022 and is projected to register the highest CAGR during the forecast period.

Regional Analysis:Geographically, the scope of the proton therapy systems market report encompasses North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In 2022, North America held the largest market share. The increasing acceptance and adoption of advanced medical devices, the high prevalence of cancer, and product innovations by key players contribute to the growth of the proton therapy systems market in North America. According to estimates from the American Cancer Society, the US recorded approximately 1.95 million new cancer cases and around 0.61 million cancer-related deaths in 2023, showing a significant rise from 1.60 million cases and 0.60 million deaths reported in 2020. As per the Particle Therapy Co-Operative Group, by the end of 2023, the US had the highest number of proton therapy systems globally, with 46 treatment facilities.

Proton Therapy Systems Market Report Scope

Industry Developments and Future Opportunities:Several strategic developments by leading players in the proton therapy systems market, as reported in company press releases, are highlighted below:

In January 2024, OncoRay introduced a prototype for a whole-body MRI-guided proton therapy system designed for real-time tracking of moving tumors using magnetic resonance imaging (MRI) during treatment. The MRI enhances tumor visualization, providing better contrast compared to traditional imaging methods, allowing for more accurate delineation of the tumor from surrounding healthy tissue and improved definition of the irradiated volume.

In December 2023, HKSH Medical Group inaugurated a new proton therapy center at the HKSH Eastern Medical Centre in A Kung Ngam, Shau Kei Wan, Hong Kong. This center features an advanced proton therapy system and two state-of-the-art treatment rooms, including two half-rotating proton therapy gantries, the latest beam transport system, and a synchrotron-based accelerator.Competitive Landscape and Key Companies:Prominent companies profiled in the proton therapy systems market report include Varian Medical Systems Inc, Sumitomo Heavy Industries Ltd, Hitachi Ltd, Ion Beam Applications SA, Mevion Medical Systems, Provision Healthcare LLC, ProTom International, Optivus Proton Therapy Inc, Advanced Oncotherapy plc, and B dot Medical Inc. These companies are focused on developing new technologies, enhancing existing products, and expanding their geographic reach to meet the increasing global demand.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Proton Therapy Systems Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Proton Therapy Systems Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Proton Therapy Systems Market - Global Market Analysis

  • 6.1 Proton Therapy Systems - Global Market Overview
  • 6.2 Proton Therapy Systems - Global Market and Forecast to 2030

7. Proton Therapy Systems Market - Revenue Analysis (USD Million) - By Set-up Type, 2020-2030

  • 7.1 Overview
  • 7.2 Single Room
  • 7.3 Multi Room

8. Proton Therapy Systems Market - Revenue Analysis (USD Million) - By Application, 2020-2030

  • 8.1 Overview
  • 8.2 Brain and Central Nervous System Cancer
  • 8.3 Head and Neck Cancer
  • 8.4 Prostate Cancer
  • 8.5 Breast Cancer
  • 8.6 Lung Cancer
  • 8.7 Gastrointestinal Cancer
  • 8.8 Others

9. Proton Therapy Systems Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

  • 9.1 North America
    • 9.1.1 North America Proton Therapy Systems Market Overview
    • 9.1.2 North America Proton Therapy Systems Market Revenue and Forecasts to 2030
    • 9.1.3 North America Proton Therapy Systems Market Revenue and Forecasts and Analysis - By Set-up Type
    • 9.1.4 North America Proton Therapy Systems Market Revenue and Forecasts and Analysis - By Application
    • 9.1.5 North America Proton Therapy Systems Market Revenue and Forecasts and Analysis - By Countries
      • 9.1.5.1 United States Proton Therapy Systems Market
        • 9.1.5.1.1 United States Proton Therapy Systems Market, by Set-up Type
        • 9.1.5.1.2 United States Proton Therapy Systems Market, by Application
      • 9.1.5.2 Canada Proton Therapy Systems Market
        • 9.1.5.2.1 Canada Proton Therapy Systems Market, by Set-up Type
        • 9.1.5.2.2 Canada Proton Therapy Systems Market, by Application
      • 9.1.5.3 Mexico Proton Therapy Systems Market
        • 9.1.5.3.1 Mexico Proton Therapy Systems Market, by Set-up Type
        • 9.1.5.3.2 Mexico Proton Therapy Systems Market, by Application
  • 9.2 Europe
    • 9.2.1 Germany
    • 9.2.2 France
    • 9.2.3 Italy
    • 9.2.4 Spain
    • 9.2.5 United Kingdom
    • 9.2.6 Rest of Europe
  • 9.3 Asia-Pacific
    • 9.3.1 Australia
    • 9.3.2 China
    • 9.3.3 India
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 Rest of Asia-Pacific
  • 9.4 Middle East and Africa
    • 9.4.1 South Africa
    • 9.4.2 Saudi Arabia
    • 9.4.3 U.A.E
    • 9.4.4 Rest of Middle East and Africa
  • 9.5 South and Central America
    • 9.5.1 Brazil
    • 9.5.2 Argentina
    • 9.5.3 Rest of South and Central America

10. Industry Landscape

  • 10.1 Mergers and Acquisitions
  • 10.2 Agreements, Collaborations, Joint Ventures
  • 10.3 New Product Launches
  • 10.4 Expansions and Other Strategic Developments

11. Competitive Landscape

  • 11.1 Heat Map Analysis by Key Players
  • 11.2 Company Positioning and Concentration

12. Proton Therapy Systems Market - Key Company Profiles

  • 12.1 Varian Medical Systems Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Hitachi Ltd
  • 12.3 Sumitomo Heavy Industries Ltd
  • 12.4 Ion Beam Applications SA
  • 12.5 Mevion Medical Systems
  • 12.6 Provision Healthcare LLC
  • 12.7 ProTom International
  • 12.8 Optivus Proton Therapy Inc
  • 12.9 Advanced Oncotherapy plc
  • 12.10 B dot Medical Inc

13. Appendix

  • 13.1 Glossary
  • 13.2 About The Insight Partners
  • 13.3 Market Intelligence Cloud